Tag: Vivasure Medical
Vivasure Medical announces first enrolment in pivotal PATCH study
Vivasure Medical has announced it has enrolled the first patients in the company’s PerQseal PATCH clinical study, a multicentre, single-arm, pivotal study evaluating the...
Vivasure Medical announces FDA IDE approval to initiate US pivotal study
Vivasure Medical has announced that the US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to advance the company’s PATCH...
Vivasure Medical announces Series D financing to advance portfolio of PerQseal...
Vivasure Medical has announced the closing of the first tranche of €22 million (US$23 million) as part of its Series D financing round that...
Vivasure Medical announces Andrew Glass as chief executive officer
Vivasure Medical recently announced that Andrew Glass has assumed the role of chief executive officer. Founder and former CEO Ger Brett will transition to...
Vivasure Medical announces launch of the PerQseal large bore closure device
Vivasure Medical has announced the European launch of the PerQseal closure device for large-bore transcatheter procedures, including transcatheter aortic valve implantation (TAVI), thoracic endovascular...
First patient enrolled in Frontier IV clinical trial of PerQseal large...
Vivasure Medical has announced the successful enrolment of the first patient in the Frontier IV clinical study, a non-randomised multicentre international trial, designed to...
